On 6 April, the UAB will be holding an institutional event entitled "Vent de l'est: guerra i pau als confins d'Europa" [Wind From the East: war and peace on the edges of Europe], in which members of the university community from Serbia, Rumania, Russia and Ukraine will share their impressions on the conflict currently taking place in Ukraine. The event will begin at 1 p.m. at the Journals Hall of the Humanities Library, at the Faculty of Arts & Humanities.
A recent work of the UAB, in collaboration with the ALBA Synchrotron, has studied the side effects of typical tooth whitening treatments, based on oxidation, compared to a new treatment developed by the authors through reduction. Results showed the whitening effect of the novel treatment to be highly improved in terms of application time needed, efficiency and safety, which makes it a promising candidate to develop novel whitening treatments. Experiments at the MIRAS beamline of ALBA helped to determine the chemical mineral modifications in the dental enamel.
Researchers of the UAB and of the Hospital del Mar have identified the presence of an ALS biomarker, the protein TDP-43, that is present outside the nucleus of skin cells of patients. The discovery can be very useful for cases in which diagnosis is difficult, or in those with a family history of ALS, and even for early diagnosis.
On 31 March, the UAB will be hosting the TEDxUABBarcelona event, a day in which different members of the university community will be speaking on issues related to “Innovative Minds”. The objective is to share the knowledge generated at the UAB considered to be transgressive and inspiring for the global community.
An international group of researchers led by the UAB analyzed the genes that are expressed in neurons and astrocytes based on data from 800 individuals and compared what happens in Alzheimer's patients and in people without diagnosed dementia. The study, published in Neurobiology of disease, highlights the need to analyze molecular markers, such as genetic sequences or brain proteins, to obtain more accurate assays, diagnoses and therapies. The results also show changes in astrocytes in an attempt to adapt to the toxic environment derived from the disease, worsening its progression.
Molecular Gate S.L. aims to become a key player in the anti-counterfeiting industry, particularly in the health sector. The cost-effective technology developed by the company will ensure the authenticity of pharmaceutical products using smart optical printed elements on the products.
Researchers from the UAB, IFAE and University College London propose using the variations in distance between the Earth and the Moon, which can be measured with a precision of less than a centimeter, as a new gravitational wave detector within a frequency range that current devices cannot detect. The research, which could pave the way for the detection of signals from the early universe, was published recently in Physical Review Letters.
The technology-based company INBRAIN Neuroelectronics will develop patented technology from CSIC, ICN2, ICREA, CIBERBBN, UAB and IDIBAPS, through an agreement recently signed with these institutions. The spin-off, which develops graphene-based applications for neurological diseases, was founded by researchers from IMB-CNM-CSIC, ICN2 and ICREA, who are also in harge of leading some of the research areas of the Graphene Flagship.
On the occasion of World Brain Week 2022, from 14 to 17 March, the UAB Institute of Neuroscience and the CORE in Mental Health have organised a new edition of talks within the Cervella't cycle. The talks will deal with, among other topics, how and why psychosis occurs, the effects of electroconvulsive therapy or how to combat obesity using virtual reality. Participation will be virtual, prior registration.
